Total Voting Rights

Summary by AI BETAClose X

AstraZeneca PLC has announced that as of August 31, 2026, its total issued share capital with voting rights stands at 1,551,043,461 ordinary shares of US$0.25, with no shares held in treasury. This figure represents the total number of voting rights and will serve as the denominator for shareholders calculating their notification obligations under the UK Financial Conduct Authority's Disclosure and Transparency Rules.

Disclaimer*

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings